Lori sought a medical solution to help her lose weight and the solution caused her body to die. I've been fortunate that my weight loss surgery has been a success in its first month and that maybe the medical world has found a solution that works for people like me. The attempt with diet pills was definitely not the answer.
If men who have sex with men must be celibate for a year, then everyone else should be held to that standard too. If they can determine risk level for heterosexuals on a case-by-case basis, then they should do it for men who have sex with men as well. Assess the risk, test the blood, and treat everyone the same. It's really that simple.
By suggesting that gay and bisexual men are at risk for HIV and straight people aren't, the FDA's guidelines misinform the public. To the extent that it contributes to ignorance of the risks associated with certain types of heterosexual sex, the FDA's policy, even in its revised form, actually presents a public-health concern.
The FDA's policy of banning "men who have had sex with other men (MSM), at any time since 1977" from donating blood does not accurately identify the behaviors that put one at risk for HIV. A policy that incorrectly identifies high-risk groups instead of high-risk behaviors is neither effective nor just.
Given current concern about the Ebola virus, it's surprising that the public isn't more alarmed about "superbugs." Superbugs are infectious bacteria that have mutated to adapt to antibiotics that were designed to kill them, making the drugs ineffective. And a major cause of the resistance problem is antibiotics administered to farm animals.
Women have the right to make their own informed choices concerning their sexual health; that gender equality should be the standard when it comes to access to treatments for sexual dysfunction; and that the approval of safe and effective treatments for women's sexual dysfunction should be a priority for action by the FDA.
You don't have to look far in medical and scientific research today to feel the shifting sands and see signs of change. At times it seems we are simultaneously tilling the soil with a set of old yet tried and true tools while making new ones. Each year, as my organization prepares to bring together leaders in medical research, we confront all of this change head on.